Assignee
VASCULAR BIOGENICS LTD
IL·35 granted patents·26 pending applications·464 citations·filing 2002–2022
Top patents by PatentIndex Score
61 records- 0196US7973023B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2009·Granted Jul 5, 2011·31 cites·51 claims
- 0296US7504388B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2005·Granted Mar 17, 2009·31 cites·7 claims
- 0396US6838452B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2003·Granted Jan 4, 2005·62 cites·11 claims
- 0495US7893291B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2009·Granted Feb 22, 2011·24 cites·3 claims
- 0595US7807847B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2007·Granted Oct 5, 2010·17 cites·7 claims
- 0695US7625882B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2006·Granted Dec 1, 2009·31 cites·56 claims
- 0793US7989427B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2008·Granted Aug 2, 2011·21 cites·6 claims
- 0893US7186704B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2003·Granted Mar 6, 2007·31 cites·16 claims
- 0992US9566288B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2015·Granted Feb 14, 2017·5 cites·35 claims
- 1092US8569529B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2012·Granted Oct 29, 2013·8 cites·20 claims
- 1192US8039261B2Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2006·Granted Oct 18, 2011·27 cites·39 claims
- 1292US7902176B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2004·Granted Mar 8, 2011·31 cites·107 claims
- 1391US11697682B2Motile sperm domain containing protein 2 antibodies and methods of use thereofVASCULAR BIOGENICS LTD·Filed 2021·Granted Jul 11, 2023·2 cites·29 claims
- 1491US8802875B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2012·Granted Aug 12, 2014·5 cites·14 claims
- 1591US7067649B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2002·Granted Jun 27, 2006·40 cites·19 claims
- 1690US9006217B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Apr 14, 2015·5 cites·22 claims
- 1790US7585666B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2002·Granted Sep 8, 2009·29 cites·5 claims
- 1889US10383954B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2017·Granted Aug 20, 2019·4 cites·18 claims
- 1989US8759557B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Jun 24, 2014·4 cites·13 claims
- 2088US7579327B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2004·Granted Aug 25, 2009·23 cites·10 claims
- 2187US9968622B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2017·Granted May 15, 2018·2 cites·18 claims
- 2287US9682154B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2014·Granted Jun 20, 2017·6 cites·20 claims
- 2384US8859747B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2013·Granted Oct 14, 2014·5 cites·31 claims
- 2483US8916378B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2013·Granted Dec 23, 2014·4 cites·20 claims
- 2582US11191848B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2019·Granted Dec 7, 2021·1 cites·16 claims
- 2681US11311583B2Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2018·Granted Apr 26, 2022·1 cites·11 claims
- 2781US9771385B2Oxidized lipidsVASCULAR BIOGENICS LTD·Filed 2015·Granted Sep 26, 2017·2 cites·37 claims
- 2878US9200056B2FAS-chimera adenovirus vectorVASCULAR BIOGENICS LTD·Filed 2014·Granted Dec 1, 2015·3 cites·23 claims
- 2977US10022388B2Oxidized lipids and treatment or prevention of fibrosisVASCULAR BIOGENICS LTD·Filed 2017·Granted Jul 17, 2018·2 cites·19 claims
- 3077US9254297B2Formulations and dosage forms of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Feb 9, 2016·5 cites·37 claims
- 3172US7279459B2Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2002·Granted Oct 9, 2007·2 cites·8 claims
- 3271US2022331383A1Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2022·Application pending·0 cites
- 3368US2010081193A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2009·Application pending·0 cites
- 3460US2013280217A1Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 3560US2013280216A1Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 3658US2010298226A1Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemiaVASCULAR BIOGENICS LTD·Filed 2007·Application pending·0 cites
- 3757US9403887B2Endothelial cell-specific polynucleotides and use thereofVASCULAR BIOGENICS LTD·Filed 2014·Granted Aug 2, 2016·0 cites·23 claims
- 3855US2013225525A1Combined Treatment Utilizing VB-201VASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 3955US2022154212A1Methods of anti-tumor therapyVASCULAR BIOGENICS LTD·Filed 2020·Application pending·0 cites
- 4055US2011201677A1Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2011·Application pending·0 cites
- 4155US2011207985A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2011·Application pending·0 cites
- 4254US2007286845A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2007·Application pending·0 cites
- 4353US2013295053A1Methods of Producing Adenovirus Vectors and Viral Preparations Generated TherebyVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 4451US10206936B2Oxidized lipids and treatment or prevention of fibrosisVASCULAR BIOGENICS LTD·Filed 2018·Granted Feb 19, 2019·0 cites·22 claims
- 4551US2016143968A1Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2015·Application pending·0 cites
- 4651US2022185891A1Methods of anti-tumor therapyVASCULAR BIOGENICS LTD·Filed 2020·Application pending·0 cites
- 4751US2014155467A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 4850US2019008880A1Formulations and Dosage Forms of Oxidized PhospholipidsVASCULAR BIOGENICS LTD·Filed 2018·Application pending·0 cites
- 4950US2005197283A1Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular diseaseVASCULAR BIOGENICS LTD·Filed 2005·Application pending·0 cites
- 5048US10369196B2Compositions and methods for treating glioblastoma GBMVASCULAR BIOGENICS LTD·Filed 2013·Granted Aug 6, 2019·0 cites·17 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VASCULAR BIOGENICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →